PMID- 11746354 OWN - NLM STAT- MEDLINE DCOM- 20020125 LR - 20111117 IS - 0360-4012 (Print) IS - 0360-4012 (Linking) VI - 66 IP - 3 DP - 2001 Nov 1 TI - Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex. PG - 369-76 AB - The effects of transforming growth factor (TGF)-beta1 on expression of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor, TrkB, in neurons cultured from the cerebral cortex of 18-day-old embryonic rats were examined. BDNF mRNA was significantly increased from 24-48 hr after the TGF-beta1 treatment over 20 ng/ml. Accumulation of BDNF protein in the culture medium was also potentiated by TGF-beta1, although the intracellular content of BDNF was nearly unchanged. The enhancement of BDNF mRNA expression was suppressed by the co-presence of decorin, a small TGF-beta-binding proteoglycan that inhibits the biological activities of TGF-betas. mRNA expression of full-length TrkB, the bioactive high-affinity receptor for BDNF, was also upregulated after treatment with TGF-beta1. These observations suggest that: 1) TGF-beta1 potentiates BDNF/TrkB autocrine or local paracrine system; and 2) the neurotrophic activity of TGF-beta1 is partly responsible for the BDNF induced by TGF-beta1 itself. To test this latter possibility, we examined the neuronal survival activity of TGF-beta1 with or without K252a, a selective inhibitor of Trk family tyrosine kinases. TGF-beta1 significantly enhanced neuronal survival, but the co-presence of K252a completely suppressed the activity, demonstrating the involvement of Trk receptor signaling in TGF-beta1-mediated neuronal survival in cultured rat cortical neurons. These results seem to be in line with recent findings by other investigators that some neurotrophic factors including BDNF require TGF-betas as a cofactor to exert their neurotrophic activities. CI - Copyright 2001 Wiley-Liss, Inc. FAU - Sometani, A AU - Sometani A AD - Laboratory of Molecular Biology, Gifu Pharmaceutical University, Gifu, Japan. FAU - Kataoka, H AU - Kataoka H FAU - Nitta, A AU - Nitta A FAU - Fukumitsu, H AU - Fukumitsu H FAU - Nomoto, H AU - Nomoto H FAU - Furukawa, S AU - Furukawa S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Neurosci Res JT - Journal of neuroscience research JID - 7600111 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Carbazoles) RN - 0 (Dcn protein, rat) RN - 0 (Decorin) RN - 0 (Enzyme Inhibitors) RN - 0 (Extracellular Matrix Proteins) RN - 0 (Indole Alkaloids) RN - 0 (Proteoglycans) RN - 0 (RNA, Messenger) RN - 0 (Tgfb1 protein, rat) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 97161-97-2 (staurosporine aglycone) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Animals MH - Autocrine Communication/drug effects/physiology MH - Brain-Derived Neurotrophic Factor/drug effects/genetics/*metabolism MH - Carbazoles/pharmacology MH - Cell Differentiation/drug effects/physiology MH - Cell Survival/drug effects/physiology MH - Cells, Cultured MH - Central Nervous System/cytology/*embryology/metabolism MH - Decorin MH - Enzyme Inhibitors/pharmacology MH - Extracellular Matrix Proteins MH - Female MH - Fetus MH - Gene Expression Regulation, Developmental/drug effects/*physiology MH - Indole Alkaloids MH - Neurons/cytology/drug effects/*metabolism MH - Pregnancy MH - Proteoglycans/metabolism/pharmacology MH - RNA, Messenger/drug effects/metabolism MH - Rats MH - Rats, Wistar MH - Receptor, trkB/*genetics MH - Time Factors MH - Transforming Growth Factor beta/*metabolism/pharmacology MH - Transforming Growth Factor beta1 MH - Up-Regulation/drug effects/*physiology EDAT- 2001/12/18 10:00 MHDA- 2002/01/26 10:01 CRDT- 2001/12/18 10:00 PHST- 2001/12/18 10:00 [pubmed] PHST- 2002/01/26 10:01 [medline] PHST- 2001/12/18 10:00 [entrez] AID - 10.1002/jnr.1229 [pii] AID - 10.1002/jnr.1229 [doi] PST - ppublish SO - J Neurosci Res. 2001 Nov 1;66(3):369-76. doi: 10.1002/jnr.1229.